Evidence map›Paper›PMID 31125670›Full record

ArticleHeart rhythm2019

SCN5A variant R222Q generated abnormal changes in cardiac sodium current and action potentials in murine myocytes and Purkinje cells.

Laura L Daniel, Tao Yang, Brett Kroncke, Lynn Hall, Dina Stroud, Dan M Roden

Open access · greenAbstract read
In one paragraph

Article in Heart rhythm, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. A novel functional variant residing outside theHeartRhythm case reports · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Laura L DanielDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee.
Tao YangDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee.
Brett KronckeDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee.
Lynn HallDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Dina StroudDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Dan M RodenDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address: dan.roden@vumc.org.
Vanderbilt University Medical Center · US

Funding

Understanding and preventing HLA-associated drug reactionsP50GM115305 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DENNY, JOSHUA C. · 2015 to 2019
$13.0M
SCN5A mutations and dilated cardiomyopathyR01HL118952 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2014 to 2017
$1.6M
SCN5A (Nav1.5): Predicting the Consequence of Missense Single- Nucleotide Polymorphisms.R00HL135442 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KRONCKE, BRETT M · 2019 to 2021
$741k
SCN5A (Nav1.5): Predicting the Consequence of Missense Single- Nucleotide Polymorphisms.K99HL135442 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KRONCKE, BRETT M · 2017 to 2018
$242k
Novel Mechanisms of Arrhythmogenesis and Dilated Cardiomyopathy in SCN5A R222Q CarriersF32HL137392 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DANIEL, LAURA L · 2017 to 2017
$18k
NHLBI NIH HHS F32 HL137392NHLBI NIH HHS K99 HL135442NHLBI NIH HHS R00 HL135442NHLBI NIH HHS R01 HL118952NIGMS NIH HHS P50 GM115305
6 · The paper itself

Abstract

backgroundThe cardiac sodium channel (SCN5A) mutation R222Q neutralizes a positive charge in the domain I voltage sensor. Mutation carriers display very frequent ectopy and dilated cardiomyopathy.

objectivesTo describe the effect of SCN5A R222Q on murine myocyte and Purkinje fiber electrophysiology, and identify underlying mechanisms.

methodsWe generated mice carrying humanized wild-type (H) and mutant (RQ) SCN5A channels. We characterized whole-heart and isolated ventricular and Purkinje myocyte properties.

resultsRQ/RQ mice were not viable. I

conclusionWhile SCN5A R222Q increases plateau inward sodium current, action potentials were unexpectedly shortened, likely reflecting an outward gating-pore current. Low extracellular potassium increased this pore current, and was arrhythmogenic in vitro and ex vivo.

Indexed as

Action PotentialsAllelesAnimalsDisease Models, AnimalEchocardiographyElectrocardiographyMiceMice, TransgenicMyocytes, CardiacNAV1.5 Voltage-Gated Sodium ChannelPurkinje CellsSodium ChannelsNAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, humanSodium ChannelsChannelopathyDilated cardiomyopathyMouse modelsSCN5ASodium channels

Identifiers

PMID31125670
PMCPMC6825529
OpenAlexW2945549317

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.